BioCentury
ARTICLE | Company News

Eisai sales and marketing update

November 24, 2014 8:00 AM UTC

Eisai launched Fycompa perampanel in Australia to treat partial-onset seizures with or without secondarily generalized seizures in epileptics ages 12 years and older. Fycompa is an AMPA-type glutamat...